A 24-person healthcare communications boutique found an unlikely door into public health: the football postseason. Its real product is not publicity, but translation under pressure.
A drug can be clinically precise and publicly unintelligible. KKH Advisors built a business in that gap - translating consequential science for the investors, reporters, partners and patients who decide what happens next.
Biotech companies can spend years waiting for their next big announcement. Bioscribe has built a communications business around the science, people, and progress in between.
A biotech PR firm put Scribe in the news one day before its co-founder won a Nobel Prize. The timing was a gamble. The preparation tells you more.